Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

VRTXVRTX
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in VERTEX PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 6M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $3B as of 2026-Q2. The position was decreased (-2.0% shares). VRTX represents 0.2% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$3B

Current Shares

6M

Total Value Change

+$223.7M

Total Shares Change

+81,960

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6M
-2.0%
$3B0.2%$496.73
0
2026-Q1
Increased
6.1M
+2.6%
$2.7B0.2%$474.27
39
2025-Q4
Increased
6M
+0.1%
$2.7B0.2%$453.74
38
2025-Q3
Increased
6M
+0.8%
$2.3B0.1%$395.31
38
2025-Q2
Increased
5.9M
+2.9%
$2.6B0.2%$441.30
39
2025-Q1
Increased
5.8M
+2.0%
$2.8B0.2%$492.69
39
2024-Q4
Decreased
5.6M
-4.8%
$2.3B0.2%$399.35
0
2024-Q3
Decreased
5.9M
-6.2%
$2.8B0.2%$462.88
0

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used